HROW - Harrow Health Inc logo

HROW

Harrow Health Inc

Harrow Health develops and commercializes ophthalmic pharmaceutical products, including compounded medications through ImprimisRx. Its portfolio features various eye drops and gels for conditions like age-related macular degeneration and bacterial conjunctivitis.

โš•๏ธ Healthcare NASDAQ Listed 2007 $ USD
$1,000 invested 10 years ago โ†’$10,171today

Score Overview

1 Year
Score
Net Growth-191.13%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth-1.33%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score6.1
Net Growth16.92%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth270.71%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth21.62%
Net Trend50%
Net Income Consistency
Rev Growth13x
Rev Trend80%
Revenue Consistency
All Time
Scoreโ€”
Net Growth-249.15%
Net Trend42%
Net Income Consistency
Rev Growthโ€”
Rev Trend79%
Revenue Consistency

See the full market ranking โ†’

Harrow Health Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 48M to $ 272M and net income went from -$ 3M to -$ 5M. Revenue increased in 4 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 9M to $ 272M and net income went from -$ 15M to -$ 5M. Revenue increased in 8 of those 10 years; net income in 5.

Harrow Health Inc currently holds a 5-year HDB Score of 6.1 out of 10. How the HDB Score is calculated.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-08-12
$ 39.36โ€”
1 Year2025-08-12
$ 34.8313.01%
5 Years2021-08-12
$ 8.90342.25%
10 Years2016-08-12
$ 3.8710x
All Time2007-09-28
$ 120.00-67.20%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 268M-$ 14M$ 94M
2025$ 272M-$ 5M$ 72M
2024$ 199M-$ 17M$ 47M
2023$ 130M-$ 24M$ 82M
2022$ 88M-$ 14M$ 96M
2021$ 72M-$ 18M$ 50M
2020$ 48M-$ 3M$ 32M
2019$ 51M$ 168K$ 29M
2018$ 41M$ 14M$ 28M
2017$ 26M-$ 11M$ 4M
2016$ 19M-$ 19M$ 8M
2015$ 9M-$ 15M$ 2M
2014$ 1M-$ 10M$ 8M
2013$ 10K-$ 7M$ 15M
2012$ 100K-$ 5M$ 10M
2011-$ 954K$ 146.16K
2010-$ 2M
2009-$ 4M$ 1M
2008-$ 3M$ 5M
IPO2007-$ 4M$ 3M

Explore beyond HROW

You're looking at Harrow Health Inc. Members apply the same fundamental framework across all 3,860 companies we cover.

$99/year $149 founding price

Unlock Holder Dashboard

30-day money-back guarantee.

Explore other companies